222 related articles for article (PubMed ID: 29274997)
1. Electroconvulsive therapy enhances the anti-ageing hormone Klotho in the cerebrospinal fluid of geriatric patients with major depression.
Hoyer C; Sartorius A; Aksay SS; Bumb JM; Janke C; Thiel M; Haffner D; Leifheit-Nestler M; Kranaster L
Eur Neuropsychopharmacol; 2018 Mar; 28(3):428-435. PubMed ID: 29274997
[TBL] [Abstract][Full Text] [Related]
2. Peripheral levels of the anti-aging hormone Klotho in patients with depression.
Sartorius A; Gilles M; Pfeifer AM; Deuschle M; Hoyer C; Haffner D; Leifheit-Nestler M; Kranaster L
J Neural Transm (Vienna); 2019 Jun; 126(6):771-776. PubMed ID: 31055648
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers for Antidepressant Efficacy of Electroconvulsive Therapy: An Exploratory Cerebrospinal Fluid Study.
Kranaster L; Hoyer C; Aksay SS; Bumb JM; Müller N; Zill P; Schwarz MJ; Moll N; Lutz B; Bindila L; Zerr I; Schmitz M; Blennow K; Zetterberg H; Haffner D; Leifheit-Nestler M; Ozbalci C; Janke C; Thiel M; Sartorius A
Neuropsychobiology; 2019; 77(1):13-22. PubMed ID: 30121652
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant efficacy of electroconvulsive therapy is associated with a reduction of the innate cellular immune activity in the cerebrospinal fluid in patients with depression.
Kranaster L; Hoyer C; Aksay SS; Bumb JM; Müller N; Zill P; Schwarz MJ; Sartorius A
World J Biol Psychiatry; 2018 Aug; 19(5):379-389. PubMed ID: 28714751
[TBL] [Abstract][Full Text] [Related]
5. Electroconvulsive therapy selectively enhances amyloid β 1-42 in the cerebrospinal fluid of patients with major depression: A prospective pilot study.
Kranaster L; Aksay SS; Bumb JM; Janke C; Alonso A; Hoyer C; Zerr I; Schmitz M; Hausner L; Frölich L; Sartorius A
Eur Neuropsychopharmacol; 2016 Dec; 26(12):1877-1884. PubMed ID: 27876183
[TBL] [Abstract][Full Text] [Related]
6. Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of patients with major depression: a preliminary prospective study.
Kranaster L; Hoyer C; Aksay SS; Bumb JM; Leweke FM; Janke C; Thiel M; Lutz B; Bindila L; Sartorius A
Eur Arch Psychiatry Clin Neurosci; 2017 Dec; 267(8):781-786. PubMed ID: 28342110
[TBL] [Abstract][Full Text] [Related]
7. Electroconvulsive therapy does not alter the synaptic protein neurogranin in the cerebrospinal fluid of patients with major depression.
Kranaster L; Blennow K; Zetterberg H; Sartorius A
J Neural Transm (Vienna); 2017 Dec; 124(12):1641-1645. PubMed ID: 29063349
[TBL] [Abstract][Full Text] [Related]
8. Reduced vascular endothelial growth factor levels in the cerebrospinal fluid in patients with treatment resistant major depression and the effects of electroconvulsive therapy-A pilot study.
Kranaster L; Blennow K; Zetterberg H; Sartorius A
J Affect Disord; 2019 Jun; 253():449-453. PubMed ID: 31103810
[TBL] [Abstract][Full Text] [Related]
9. Electroconvulsive Therapy in the Elderly: New Findings in Geriatric Depression.
Geduldig ET; Kellner CH
Curr Psychiatry Rep; 2016 Apr; 18(4):40. PubMed ID: 26909702
[TBL] [Abstract][Full Text] [Related]
10. Depressive Symptom Dimensions in Treatment-Resistant Major Depression and Their Modulation With Electroconvulsive Therapy.
Wade BSC; Hellemann G; Espinoza RT; Woods RP; Joshi SH; Redlich R; Jørgensen A; Abbott CC; Oedegaard KJ; McClintock SM; Oltedal L; Narr KL
J ECT; 2020 Jun; 36(2):123-129. PubMed ID: 31464814
[TBL] [Abstract][Full Text] [Related]
11. Long-term treatment strategies in major depression: a 2-year prospective naturalistic follow-up after successful electroconvulsive therapy.
Martínez-Amorós E; Cardoner N; Soria V; Gálvez V; Menchón JM; Urretavizcaya M
J ECT; 2012 Jun; 28(2):92-7. PubMed ID: 22531201
[TBL] [Abstract][Full Text] [Related]
12. Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder.
Ghasemi M; Kazemi MH; Yoosefi A; Ghasemi A; Paragomi P; Amini H; Afzali MH
Psychiatry Res; 2014 Feb; 215(2):355-61. PubMed ID: 24374115
[TBL] [Abstract][Full Text] [Related]
13. The novel seizure quality index for the antidepressant outcome prediction in electroconvulsive therapy: association with biomarkers in the cerebrospinal fluid.
Kranaster L; Hoyer C; Mindt S; Neumaier M; Müller N; Zill P; Schwarz MJ; Moll N; Lutz B; Bindila L; Zerr I; Schmitz M; Blennow K; Zetterberg H; Haffner D; Leifheit-Nestler M; Ozbalci C; Sartorius A
Eur Arch Psychiatry Clin Neurosci; 2020 Oct; 270(7):911-919. PubMed ID: 31760473
[TBL] [Abstract][Full Text] [Related]
14. Electroconvulsive therapy (ECT) and aerobic exercise training (AET) increased plasma BDNF and ameliorated depressive symptoms in patients suffering from major depressive disorder.
Salehi I; Hosseini SM; Haghighi M; Jahangard L; Bajoghli H; Gerber M; Pühse U; Holsboer-Trachsler E; Brand S
J Psychiatr Res; 2016 May; 76():1-8. PubMed ID: 26859236
[TBL] [Abstract][Full Text] [Related]
15. Serum lipid profile changes after successful treatment with electroconvulsive therapy in major depression: A prospective pilot trial.
Aksay SS; Bumb JM; Janke C; Biemann R; Borucki K; Lederbogen F; Deuschle M; Sartorius A; Kranaster L
J Affect Disord; 2016 Jan; 189():85-8. PubMed ID: 26426831
[TBL] [Abstract][Full Text] [Related]
16. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE).
Kellner CH; Knapp RG; Petrides G; Rummans TA; Husain MM; Rasmussen K; Mueller M; Bernstein HJ; O'Connor K; Smith G; Biggs M; Bailine SH; Malur C; Yim E; McClintock S; Sampson S; Fink M
Arch Gen Psychiatry; 2006 Dec; 63(12):1337-44. PubMed ID: 17146008
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and cognitive side effects after brief pulse and ultrabrief pulse right unilateral electroconvulsive therapy for major depression: a randomized, double-blind, controlled study.
Spaans HP; Verwijk E; Comijs HC; Kok RM; Sienaert P; Bouckaert F; Fannes K; Vandepoel K; Scherder EJ; Stek ML; Kho KH
J Clin Psychiatry; 2013 Nov; 74(11):e1029-36. PubMed ID: 24330903
[TBL] [Abstract][Full Text] [Related]
18. Prediction of Individual Response to Electroconvulsive Therapy via Machine Learning on Structural Magnetic Resonance Imaging Data.
Redlich R; Opel N; Grotegerd D; Dohm K; Zaremba D; Bürger C; Münker S; Mühlmann L; Wahl P; Heindel W; Arolt V; Alferink J; Zwanzger P; Zavorotnyy M; Kugel H; Dannlowski U
JAMA Psychiatry; 2016 Jun; 73(6):557-64. PubMed ID: 27145449
[TBL] [Abstract][Full Text] [Related]
19. The Global ECT-MRI Research Collaboration (GEMRIC): Establishing a multi-site investigation of the neural mechanisms underlying response to electroconvulsive therapy.
Oltedal L; Bartsch H; Sørhaug OJ; Kessler U; Abbott C; Dols A; Stek ML; Ersland L; Emsell L; van Eijndhoven P; Argyelan M; Tendolkar I; Nordanskog P; Hamilton P; Jorgensen MB; Sommer IE; Heringa SM; Draganski B; Redlich R; Dannlowski U; Kugel H; Bouckaert F; Sienaert P; Anand A; Espinoza R; Narr KL; Holland D; Dale AM; Oedegaard KJ
Neuroimage Clin; 2017; 14():422-432. PubMed ID: 28275543
[TBL] [Abstract][Full Text] [Related]
20. Cognitive-behavioral therapy as continuation treatment to sustain response after electroconvulsive therapy in depression: a randomized controlled trial.
Brakemeier EL; Merkl A; Wilbertz G; Quante A; Regen F; Bührsch N; van Hall F; Kischkel E; Danker-Hopfe H; Anghelescu I; Heuser I; Kathmann N; Bajbouj M
Biol Psychiatry; 2014 Aug; 76(3):194-202. PubMed ID: 24462229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
